RenovoRx Inc. (NASDAQ: RNXT) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT RENOVORX INC.

RenovoRx Inc. (NASDAQ: RNXT)
Listen to this Section


$0.95
+0.0464 ( +5.12% ) 323.6K

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Market Data


Open $0.95
Previous Close $0.91
Volume 323.6K
Market Cap $40.84M
Day Range $0.89 - $0.98
52 Week Range $0.70 - $1.45
Shares Outstanding 45.10M
Change % +5.12%
Net Change ▲ 0.0464
Insider Ownership -0.01%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2021
CountryUnited States
UnderwriterRoth Capital, Maxim Group LLC, more

Insider Ownership Transactions

Total Amount Purchased: -130,587.00

Date Type Amount Purchased Purchaser
2024-01-23 Sale -66973.00 Bagai Shaun
2023-10-04 Buy 300.00 Nelms Angela
2023-10-02 Sale -25099.00 Spiegel Robert J.
2023-10-02 Sale -25099.00 RYAN UNA S
2023-10-02 Sale -25099.00 Marton Laurence
2023-10-02 Sale -25099.00 Macfarlane K. Angela
2023-10-02 Sale -25099.00 Diamond David

SEC Filings


Form Type Description Pages Date
8-k 8K-related 16 Nov 14, 2025
424b5 Other 4 Nov 14, 2025
s-3 Registration statements 19 Nov 14, 2025
8-k 8K-related 13 Nov 13, 2025
10-q Quarterly Reports 77 Nov 13, 2025
4 Insider transactions 1 Oct 03, 2025
4 Insider transactions 1 Oct 02, 2025
4 Insider transactions 1 Oct 02, 2025
4 Insider transactions 1 Oct 02, 2025
4 Insider transactions 1 Aug 26, 2025

Latest News


× Before browsing our site, please accept our cookies policy